Andrew I'm not overly concerned about obtaining tissue specific absorption with systemic administration. Too difficult to achieve. The alternative is to deliver a promising choice via direct arterial organ cannulation as with dye injection for angiograms, though repeated administration could be an issue under that scenario.
Are there any drugs currently in use that have organ/tissue specific pharmacokinetics that do not depend on cell receptors?
- Forums
- ASX - By Stock
- PYC
- Ann: CEO letter and Operational Update
PYC
pyc therapeutics limited
Add to My Watchlist
1.77%
!
$1.15

Ann: CEO letter and Operational Update, page-17
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.15 |
Change
0.020(1.77%) |
Mkt cap ! $670.7M |
Open | High | Low | Value | Volume |
$1.15 | $1.18 | $1.11 | $172.3K | 151.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 592 | $1.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.16 | 4211 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | 1.120 |
3 | 9261 | 1.100 |
1 | 2000 | 1.050 |
2 | 33803 | 1.000 |
1 | 1020 | 0.980 |
Price($) | Vol. | No. |
---|---|---|
1.160 | 4211 | 1 |
1.175 | 10000 | 1 |
1.180 | 33000 | 2 |
1.200 | 25749 | 4 |
1.205 | 2270 | 1 |
Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |